Canagliflozin: Frequently Asked Questions Answered
What Is Canagliflozin?
Canagliflozin comes from a category of medicine known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Canagliflozin is usually used alongside recommended diet and exercise to lower blood sugar levels in people with diabetes. It will not lessen the danger of stroke, attack, or death in people with type 2 diabetes alongside heart and vessel disease. Canagliflozin additionally won’t diminish the threat of end-stage renal disorder, worsening of kidney function, hospitalization for coronary failure, and cardiovascular death in people with type 2 diabetes alongside severe renal illness. It lowers blood glucose by causing the kidneys to urge to obviate more glucose within the urine.
What Are The Uses Of Canagliflozin?
Canagliflozin comes in tablet form, and patients are typically prescribed a dose of the medicine with regular exercise and a nutritious diet. Canagliflozin tablet use lowers blood sugar levels in patients with type 2 diabetes. Patients at risk of stroke, heart attack, or signs of kidney disease can also be prescribed a Canagliflozin tablet. Canagliflozin is not used to treat patients with type 1 diabetes; however, it can lower the sugar amount in urine.